Limited time75% off all plans
Get the app

Urticaria and Angioedema

On this page

Urticaria & Angioedema - Defining the Duo

  • Urticaria (Hives)

    • Superficial dermal edema presenting as wheals.
    • Intensely pruritic, erythematous, circumscribed, raised, blanching plaques.
    • Individual lesions transient, lasting < 24 hours.
    • No post-inflammatory changes.
  • Angioedema

    • Deeper edema: dermis, subcutaneous tissue, or submucosa.
    • Common sites: face, lips, tongue, larynx, extremities, genitalia.
    • Often painful or burning; pruritus usually absent or mild.
    • Slower onset; resolves over 24-72 hours.
    • Laryngeal involvement can be life-threatening.

Urticaria and angioedema clinical presentation

  • Urticaria & Angioedema often coexist (40-50%); angioedema alone (10%), urticaria alone (~40-50%).

⭐ Hereditary Angioedema (HAE) is often associated with C1 esterase inhibitor deficiency/dysfunction and does NOT typically present with urticaria or pruritus.

Mechanisms & Categories - How & What Type

  • Mechanisms:
    • Histaminergic: Mast cell degranulation (Histamine, Prostaglandins, Leukotrienes) → Urticaria (wheals) & some Angioedema. Typically pruritic.
    • Bradykininergic: ↑ Bradykinin (e.g., due to C1-INH deficiency or ACE inhibitors) → Angioedema (deeper swelling). Typically non-pruritic, no wheals.
  • Urticaria Types:
    • Acute: < 6 weeks duration.
    • Chronic: > 6 weeks duration.
      • Chronic Spontaneous Urticaria (CSU).
      • Chronic Inducible Urticaria (CIndU) - e.g., symptomatic dermographism, cold urticaria, cholinergic urticaria.
  • Angioedema (AE) Types:
    • With Urticaria (Histaminergic): Allergic, idiopathic spontaneous, secondary to CIndU.
    • Without Urticaria (Primarily Bradykininergic):
      • Hereditary Angioedema (HAE): C1-INH deficiency (Type I) or dysfunction (Type II), or HAE with normal C1-INH.
      • Acquired Angioedema (AAE): C1-INH deficiency.
      • ACE Inhibitor-induced Angioedema.
      • Idiopathic Non-Histaminergic Angioedema.

Pathways of histaminergic and bradykininergic angioedema

⭐ Hereditary Angioedema (HAE) Type I is characterized by low C1-INH levels and function, while HAE Type II has normal (or elevated) C1-INH levels but impaired function. Both result in unregulated bradykinin production during attacks.

Causes & Child Triggers - The Usual Suspects

  • Infections (Key trigger in children):
    • Viral (URI), bacterial (Strep, Mycoplasma), parasitic.
  • Food Allergens:
    • Milk, egg, peanut, tree nuts, soy, wheat, fish, shellfish.
    • Food additives (rare: benzoates, tartrazine).
  • Drugs:
    • Antibiotics (β-lactams, sulfonamides), NSAIDs.
    • Opiates, radiocontrast (non-allergic histamine release).
  • Physical Urticarias:
    • Dermatographism (commonest), cold, cholinergic (heat/exercise), solar, pressure.
  • Insect Bites/Stings:
    • Bees, wasps, ants, mosquitoes.
  • Contact/Inhalants:
    • Latex, dander, pollen, dust mites.
  • Idiopathic: Common, especially chronic cases.

⭐ Infections are the primary trigger for acute urticaria in children.

Workup & Treatment - Solving & Soothing

  • Workup: Identify triggers; differentiate acute (<6 wks) vs. chronic (>6 wks).
    • Acute: Clinical diagnosis. Tests if recurrent/severe.
    • Chronic (CSU): CBC, ESR/CRP. Consider thyroid Abs, specific IgE.
    • Angioedema (no wheals): C4, C1-INH level & function (HAE screen).
  • Treatment:
    • Avoid triggers. H1-antihistamines (2nd gen preferred, e.g., Cetirizine) are mainstay.
    • CSU: Step-up H1 dose (up to 4x), then Omalizumab, then Cyclosporine.
    • Severe Acute: Short course OCS (Prednisolone 0.5-1 mg/kg/day, 3-7 days). Epinephrine if anaphylaxis.
    • HAE: Acute (C1-INH concentrate, Icatibant); Prophylaxis (C1-INH, Lanadelumab). FFP if others unavailable.

⭐ Omalizumab, an anti-IgE monoclonal antibody, is a key treatment for refractory chronic spontaneous urticaria not responding to high-dose antihistamines.

High‑Yield Points - ⚔ Biggest Takeaways

  • Urticaria: transient, pruritic wheals. Angioedema: deeper, non-pruritic swelling; laryngeal involvement is critical.
  • Differentiate acute (<6 weeks) from chronic (>6 weeks) urticaria.
  • Key mechanism: mast cell degranulation releasing histamine.
  • First-line: second-generation H1 antihistamines for symptomatic relief.
  • Hereditary Angioedema (HAE): bradykinin-mediated, C1-inhibitor deficient; antihistamines/steroids are ineffective.
  • Common triggers: infections, drugs (NSAIDs, antibiotics), foods.
  • In anaphylaxis with urticaria/angioedema, epinephrine is life-saving.

Continue reading on Oncourse

Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.

CONTINUE READING — FREE

or get the app

Rezzy — Oncourse's AI Study Mate

Have doubts about this lesson?

Ask Rezzy, your AI Study Mate, to explain anything you didn't understand

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

START FOR FREE